Equity Incentive Plan (Tables)

3 Months Ended

Mar. 31, 2020

Schedule of Additional Information on Stock Option Grants And Vesting

The following table summarizes additional information on stock option grants and vesting (in thousands):

	2016 Plan				2019 Plan
	Three Months Ended March 31, 2020		Three Months Ended March 31, 2019		Three Months Ended March 31, 2020		Three Months Ended March 31, 2019
Total fair value of stock options granted	$	-	$	2,492	$	7,970	$	-
Total fair value of options vested		-		815		-		-

Summary of Valuation Models of Fair Value of Awards Granted To Employees and Non-Employees Under 2016 Plan

The following table summarizes the assumptions used in the valuation models to determine the fair value of awards granted to employees and non- employees under both the 2019 Plan and the 2016 Plan:

	Three Months Ended March 31, 2020	Three Months Ended March 31, 2019
Expected volatility	37.63%	36.92%
Expected term (in years)	6.0	6.5
Dividend yield	0.00%	0.00%
Risk free interest rate	1.43%	2.42%

Stock Based Compensation Expense Included In Consolidated Statements of Comprehensive Loss

Stock-based compensation expense is included in the Company’s Consolidated Statements of Comprehensive Loss within the following line items (in thousands):

	Three Months Ended March 31, 2020		Three Months Ended March 31, 2019
Cost of revenues	$	355	$	231
General and administrative		230		619
Research and development		73		4
Sales and marketing		167		56
Total	$	825	$	910

2019 Plan [Member]

Schedule of Stock Option Activity Under 2019 Plan

The following table summarizes the Company’s stock option activity under the 2019 Plan:

Description	Options Outstanding			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value (1)
Balance at December 31, 2019		514,710		$	9.90		10.0	$	-
Granted		3,475,045			8.00
Forfeited		(19,536	)		8.00
Expired		-
Balance at March 31, 2020		3,970,219		$	8.25		9.7	$	-
Vested and expected to vest		3,970,219		$	8.25		9.7	$	-
Exercisable		-		$	-		-	$	-

(1) Aggregate intrinsic value represents the difference between the estimated fair value of the underlying Common Stock (as defined below) and the exercise price of outstanding, in-the-money options. There were no in-the-money options as of March 31, 2020 and December 31, 2019.